Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Section Chief Medical Oncology
mi
from
Houston, TX
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Section Chief Medical Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Jose A Figueroa, MD
mi
from
Lubbock, TX
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Jose A Figueroa, MD
mi
from
Lubbock, TX
Click here to add this to my saved trials
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Southlake Oncology
mi
from
Southlake, TX
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Southlake Oncology
mi
from
Southlake, TX
Click here to add this to my saved trials
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Peninsula Cancer Institute
mi
from
Newport News, VA
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Providence Cancer Center
mi
from
Spokane, WA
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Providence Cancer Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  2/9/2016
Leah L Dietrich, MD
mi
from
La Crosse, WI
Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
IXTEND: A Randomized Phase 2 Study to Evaluate the Combination of Ixabepilone Plus Capecitabine or Capecitabine Plus Docetaxel in the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 2/9/2016
Leah L Dietrich, MD
mi
from
La Crosse, WI
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Birmingham Hematology and Oncology Associates, LLC
mi
from
Birmingham, AL
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Birmingham Hematology and Oncology Associates, LLC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Hematology Oncology Associates
mi
from
Phoenix, AZ
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Hematology Oncology Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Northern Arizona Hematology & Oncology Associates
mi
from
Sedona, AZ
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Northern Arizona Hematology & Oncology Associates
mi
from
Sedona, AZ
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Arizona Oncology Associates D.B.A. Hematology Oncology
mi
from
Tucson, AZ
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Arizona Oncology Associates D.B.A. Hematology Oncology
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Southwest Cancer Care
mi
from
Murrieta, CA
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Southwest Cancer Care
mi
from
Murrieta, CA
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Florida Cancer Institute
mi
from
Hudson, FL
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Florida Cancer Institute
mi
from
Hudson, FL
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Ocala Oncology Center
mi
from
Ocala, FL
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Ocala Oncology Center
mi
from
Ocala, FL
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Cancer Centers of Florida
mi
from
Ocoee, FL
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Cancer Centers of Florida
mi
from
Ocoee, FL
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Cancer Care & Hematology Specialists of Chicagoland
mi
from
Niles, IL
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Cancer Care & Hematology Specialists of Chicagoland
mi
from
Niles, IL
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Central Indiana Cancer Centers
mi
from
Carmel, IN
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Central Indiana Cancer Centers
mi
from
Carmel, IN
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Hope Center
mi
from
Terre Haute, IN
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Hope Center
mi
from
Terre Haute, IN
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Alliance Hematology Oncology PA.
mi
from
Westminster, MD
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Minnesota Oncology and Hematology, PA
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Missouri Cancer Associates
mi
from
Columbia, MO
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Missouri Cancer Associates
mi
from
Columbia, MO
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Kansas City Cancer Center
mi
from
Kansas City, MO
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Kansas City Cancer Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Arch Medical Services
mi
from
St. Louis, MO
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Arch Medical Services
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Comprehensive Cancer Center of Nevada
mi
from
Henderson, NV
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Comprehensive Cancer Center of Nevada
mi
from
Henderson, NV
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Hematology-Oncology Assoc. Of Northern Nj, Pa
mi
from
Morristown, NJ
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Hematology-Oncology Assoc. Of Northern Nj, Pa
mi
from
Morristown, NJ
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
New Mexico Cancer Care Associates
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
New York Oncology Hematology, P.C.
mi
from
Amsterdam, NY
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
New York Oncology Hematology, P.C.
mi
from
Amsterdam, NY
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Interlakes Oncology/Hematology PC
mi
from
Rochester, NY
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Interlakes Oncology/Hematology PC
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Regional Cancer Care, PA
mi
from
Durham, NC
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Regional Cancer Care, PA
mi
from
Durham, NC
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Raleigh Hematology Oncology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Cancer Centers of the Carolinas
mi
from
Greenville, SC
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center
mi
from
Arlington, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology-Central Austin Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Mamie Mcfaddin Ward Cancer Center Texas Oncology
mi
from
Beaumont, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Bedord, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Bedord, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center At Medical City
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center At Medical City
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology, PA
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology/Methodist Charlton Cancer Ctr.
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Baylor Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center
mi
from
Denton, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center
mi
from
Denton, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology P.A.
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology PA
mi
from
Garland, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology PA
mi
from
Garland, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Houston, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology, PA at Lake Vista Cancer Center
mi
from
Lewisville, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology, PA at Lake Vista Cancer Center
mi
from
Lewisville, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Longview Cancer Center
mi
from
Longview, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Longview Cancer Center
mi
from
Longview, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
South Texas Cancer Center
mi
from
McAllen, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
South Texas Cancer Center
mi
from
McAllen, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Cancer Center of Mesquite
mi
from
Mesquite, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Cancer Center of Mesquite
mi
from
Mesquite, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology
mi
from
Midland, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology
mi
from
Midland, TX
Click here to add this to my saved trials
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated:  2/9/2016
Texas Oncology - Odessa
mi
from
Odessa, TX
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
Phase II Randomized Trial of Weekly and Every 3-week Ixabepilone in Metastatic Breast Cancer (MBC) Patients
Status: Enrolling
Updated: 2/9/2016
Texas Oncology - Odessa
mi
from
Odessa, TX
Click here to add this to my saved trials